[Alveolar haemorrhage associated with the primary antiphospholipid syndrome].

Rev Mal Respir

Service de pneumologie et de réanimation, hôpital Hôtel Dieu, BP 16-6830, Beyrouth, Liban.

Published: January 2013

Introduction: Thrombotic events, particularly pulmonary embolism, are well known presentations of the antiphospholipid syndrome. Other pulmonary manifestations of the disease like alveolar haemorrhage are rare but can represent a catastrophic aspect of this disease. Alveolar haemorrhage in this context is important to recognize since it can be either a complication of anticoagulation therapy or a manifestation of the disease. The therapeutic implications are then very different.

Case Presentation: We present the case of a woman with massive pulmonary embolism treated with thrombolytic therapy. This was complicated by alveolar hemorrhage initially attributed to thrombolytics and recurrent bleeding considered to be a manifestation of the antiphospholipid syndrome. The complicated course necessitated a protracted stay in the intensive care unit, mechanical ventilation, and treatment with intravenous corticosteroids and plasmapheresis.

Conclusion: Alveolar haemorrhage associated with the antiphospholipid syndrome can be catastrophic and require prompt and aggressive therapy. Plasmapheresis, usually reserved for the catastrophic aspects of this condition, was felt to be useful in this case.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmr.2012.09.018DOI Listing

Publication Analysis

Top Keywords

antiphospholipid syndrome
12
alveolar haemorrhage
12
haemorrhage associated
8
pulmonary embolism
8
disease alveolar
8
[alveolar haemorrhage
4
associated primary
4
antiphospholipid
4
primary antiphospholipid
4
antiphospholipid syndrome]
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!